128 related articles for article (PubMed ID: 35526615)
1. OCTA changes following loading phase with intravitreal aflibercept for DME.
Kansal V; Colleaux K; Rawlings N
Can J Ophthalmol; 2023 Oct; 58(5):480-490. PubMed ID: 35526615
[TBL] [Abstract][Full Text] [Related]
2. Optical Coherence Tomography Angiography in Diabetic Macular Edema Treated with Intravitreal Aflibercept: A 48-Week Observational Study (the DOCTA Study).
Korobelnik JF; Gaucher D; Baillif S; Creuzot-Garcher C; Kodjikian L; Weber M
Ophthalmologica; 2023; 246(2):71-80. PubMed ID: 36646050
[TBL] [Abstract][Full Text] [Related]
3. OCT Angiography Biomarkers for Predicting Visual Outcomes after Ranibizumab Treatment for Diabetic Macular Edema.
Hsieh YT; Alam MN; Le D; Hsiao CC; Yang CH; Chao DL; Yao X
Ophthalmol Retina; 2019 Oct; 3(10):826-834. PubMed ID: 31227330
[TBL] [Abstract][Full Text] [Related]
4. Vessel Density Changes on Optical Coherence Tomography Angiography after Vascular Endothelial Growth Factor Inhibitor Treatment for Diabetic Macular Edema.
Cheong KX; Lee SY; Ang M; Teo KYC
Turk J Ophthalmol; 2020 Dec; 50(6):343-350. PubMed ID: 33389934
[TBL] [Abstract][Full Text] [Related]
5. Predicting visual outcomes following anti-vascular endothelial growth factor treatment for diabetic macular edema.
Rana V; Agarwal A; Arora A; Bansal R; Dogra M; Bhadada SK; Singh N; Gupta V
Indian J Ophthalmol; 2024 Jan; 72(Suppl 1):S16-S21. PubMed ID: 38131536
[TBL] [Abstract][Full Text] [Related]
6. Optical Coherence Tomography Angiography Analysis of the Foveal Avascular Zone and Macular Vessel Density After Anti-VEGF Therapy in Eyes With Diabetic Macular Edema and Retinal Vein Occlusion.
Ghasemi Falavarjani K; Iafe NA; Hubschman JP; Tsui I; Sadda SR; Sarraf D
Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):30-34. PubMed ID: 28114569
[TBL] [Abstract][Full Text] [Related]
7. Association of Intravitreal Aflibercept With Optical Coherence Tomography Angiography Vessel Density in Patients With Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
Alagorie AR; Nittala MG; Velaga S; Zhou B; Rusakevich AM; Wykoff CC; Sadda SR
JAMA Ophthalmol; 2020 Aug; 138(8):851-857. PubMed ID: 32584384
[TBL] [Abstract][Full Text] [Related]
8. Macular vessels density in diabetic retinopathy: quantitative assessment using optical coherence tomography angiography.
AttaAllah HR; Mohamed AAM; Ali MA
Int Ophthalmol; 2019 Aug; 39(8):1845-1859. PubMed ID: 30194547
[TBL] [Abstract][Full Text] [Related]
9. Optical Coherence Tomography Angiography of DME and Its Association with Anti-VEGF Treatment Response.
Lee J; Moon BG; Cho AR; Yoon YH
Ophthalmology; 2016 Nov; 123(11):2368-2375. PubMed ID: 27613201
[TBL] [Abstract][Full Text] [Related]
10. Retinal Microvasculature and Visual Acuity after Intravitreal Aflibercept in Diabetic Macular Edema: An Optical Coherence Tomography Angiography Study.
Busch C; Wakabayashi T; Sato T; Fukushima Y; Hara C; Shiraki N; Winegarner A; Nishida K; Sakaguchi H; Nishida K
Sci Rep; 2019 Feb; 9(1):1561. PubMed ID: 30733512
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of macular vascular density and foveal avascular zone changes by optical coherence tomography angiography (OCT-A) after intravitreal dexamethasone implant in diabetic macular edema resistant to Anti-VEGF treatment.
Ceylan A; Dogan ME; Demircan A; Akar Y
Int Ophthalmol; 2022 Nov; 42(11):3579-3588. PubMed ID: 35737210
[TBL] [Abstract][Full Text] [Related]
12. SUSPENDED SCATTERING PARTICLES IN MOTION MAY INFLUENCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY VESSEL DENSITY METRICS IN EYES WITH DIABETIC MACULAR EDEMA.
Maltsev DS; Kulikov AN; Kazak AA; Freund KB
Retina; 2021 Jun; 41(6):1259-1264. PubMed ID: 33165296
[TBL] [Abstract][Full Text] [Related]
13. MEASUREMENTS OF RETINAL FLUID BY OPTICAL COHERENCE TOMOGRAPHY LEAKAGE IN DIABETIC MACULAR EDEMA: A Biomarker of Visual Acuity Response to Treatment.
Santos AR; Alves D; Santos T; Figueira J; Silva R; Cunha-Vaz JG
Retina; 2019 Jan; 39(1):52-60. PubMed ID: 29077605
[TBL] [Abstract][Full Text] [Related]
14. Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor.
Couturier A; Rey PA; Erginay A; Lavia C; Bonnin S; Dupas B; Gaudric A; Tadayoni R
Ophthalmology; 2019 Dec; 126(12):1685-1694. PubMed ID: 31383483
[TBL] [Abstract][Full Text] [Related]
15. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy.
Sorour OA; Sabrosa AS; Yasin Alibhai A; Arya M; Ishibazawa A; Witkin AJ; Baumal CR; Duker JS; Waheed NK
Int Ophthalmol; 2019 Oct; 39(10):2361-2371. PubMed ID: 31119505
[TBL] [Abstract][Full Text] [Related]
16. Optical coherence tomography angiography analysis of microvascular abnormalities and vessel density in treatment-naïve eyes with diabetic macular edema.
Braham IZ; Kaouel H; Boukari M; Ammous I; Errais K; Boussen IM; Zhioua R
BMC Ophthalmol; 2022 Nov; 22(1):418. PubMed ID: 36329416
[TBL] [Abstract][Full Text] [Related]
17. Angiographic biomarkers are significant predictors of treatment response to intravitreal aflibercept in diabetic macular edema.
Hein M; Vukmirovic A; Constable IJ; Raja V; Athwal A; Freund KB; Balaratnasingam C
Sci Rep; 2023 May; 13(1):8128. PubMed ID: 37208427
[TBL] [Abstract][Full Text] [Related]
18. OCT Angiography Study of the Macula in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept.
Dastiridou A; Karathanou K; Riga P; Anagnostopoulou S; Balasubramanian S; Mataftsi A; Brazitikos P; Ziakas N; Androudi S
Ocul Immunol Inflamm; 2021 Jul; 29(5):926-931. PubMed ID: 31951761
[No Abstract] [Full Text] [Related]
19. Longitudinal Panretinal Leakage and Ischemic Indices in Retinal Vascular Disease after Aflibercept Therapy: The PERMEATE Study.
Figueiredo N; Srivastava SK; Singh RP; Babiuch A; Sharma S; Rachitskaya A; Talcott K; Reese J; Hu M; Ehlers JP
Ophthalmol Retina; 2020 Feb; 4(2):154-163. PubMed ID: 31757691
[TBL] [Abstract][Full Text] [Related]
20. Retinal Layers Changes in Patients with Diabetic Macular Edema Treated with Intravitreal Anti-VEGF Agents: Long-Term Outcomes of a Spectral-Domain OCT Study.
Chatziralli I; Kazantzis D; Theodossiadis G; Theodossiadis P; Sergentanis TN
Ophthalmic Res; 2021; 64(2):230-236. PubMed ID: 32564022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
